spot-mrna01
Biologicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 15, 2024 (NCT06438341)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Collagen alpha-1(I) chainSupplementation
COL1A1 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06567119 | Phase 1 | Oct 1, 2024 | Jiao Tong University, SIPO Biotechnology Co. Ltd. |
| NCT06438341 | Phase 1 | Jun 15, 2024 | Jiao Tong University, Spot Biosystems Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiao Tong University | Academic/Hospital | 2 | 0 | 1 | 2024 |
| SIPO Biotechnology Co. Ltd. | For profit | 1 | 1 | 1 | 2024 |
| Spot Biosystems Ltd. | For profit | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1